Vaccines | Free Full-Text | Budget Impact Analysis of Fixed Dose Versus Weight-Based Dosing Regimen of Nivolumab and Pembrolizumab in the Treatment of Non-Small Cell Lung Cancer
THE COST-EFFECTIVENESS OF THREE PREVENTION STRATEGIES IN ALZHEIMER'S DISEASE: RESULTS FROM THE MULTIDOMAIN ALZHEIMER PREVENTIVE TRIAL (MAPT) • The Journal of Prevention of Alzheimer's Disease
Association des POIC - La base AMELI a enfin été mise à jour concernant la retrocession de la Trimebutine injectable. Aucune pharmacie centrale ne peut, désormais, refuser de la délivrer (sur prescription
Supplementary materials Methods Calculation of costs and HCRU A cost of €24.13, which included official tariffs and surcharges
PandaLab | La messagerie médicale au coeur de votre pratique
utilisation des médicaments dans les maisons de soins - KCE
Cost-Effectiveness of Dolutegravir in HIV-1 Treatment-Experienced (TE) Patients in France | PLOS ONE
Cost-effectiveness of TLC-NOSF dressings versus neutral dressings for the treatment of diabetic foot ulcers in France | PLOS ONE
PDF) The economic burden of urinary tract infections in women visiting general practices in France: A cross-sectional survey
Patient access to orphan drugs in France | Orphanet Journal of Rare Diseases | Full Text
CIP ACL - Nouvelle version des bases de données avril 2019
POMME: The New Cohort to Evaluate Long-Term Effects After Prenatal Medicine Exposure | SpringerLink
La base de données médicaments Thériaque - CNHIM
THE COST-EFFECTIVENESS OF THREE PREVENTION STRATEGIES IN ALZHEIMER'S DISEASE: RESULTS FROM THE MULTIDOMAIN ALZHEIMER PREVENTIVE TRIAL (MAPT) • The Journal of Prevention of Alzheimer's Disease
Cost-utility analysis of atezolizumab with bevacizumab in untreated unresectable or advanced hepatocellular carcinoma in France | PLOS ONE
THE COST-EFFECTIVENESS OF THREE PREVENTION STRATEGIES IN ALZHEIMER'S DISEASE: RESULTS FROM THE MULTIDOMAIN ALZHEIMER PREVENTIVE TRIAL (MAPT) • The Journal of Prevention of Alzheimer's Disease
OFFRE D'EMPLOI : Responsable Technico-Commercial en Transit (H/F) - Africa Supply Chain
La libre fixation des prix des médicaments financés dans les groupes homogènes de séjour hospitalier : une exception au régime des prix administrés des médicaments à conserver ? | Cairn.info
Should We Prevent Off-Label Drug Prescriptions? Empirical Evidence from France”
Impact of Gastric Electrical Stimulation on Economic Burden of Refractory Vomiting: A French Nationwide Multicentre Study - Clinical Gastroenterology and Hepatology
Nouvelle indemnisation transparente pour les médicaments soumis à ordonnance | Communauté d'achat HSK SA
Hepatitis B or Delta liver transplant patients at risk of recurrence: Long-term effectiveness and budget impact of low-dose subcutaneous anti-hepatitis B immunoglobulin plus patient education program - ScienceDirect
Competition From Biosimilars Drives Price Reductions For Biologics In The French Single-Payer Health System | Health Affairs
